Encompass Health Corporation with ticker code (EHC) now have 11 market analysts covering the stock. The analyst consensus now points to a rating of ‘Buy’. The target price High/Low ranges between 75 and 61 calculating the mean target price we have $70.09. Now with the previous closing price of $60.75 and the analysts are correct then there would likely be a percentage uptick in value of 15.4%. Also worth taking note is the 50 day moving average now sits at $57.38 and the 200 day MA is $54.02. The market capitalization for the company is $6,149m. Find out more information at: https://www.encompasshealth.com
The potential market cap would be $7,095m based on the market consensus.
Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides services under the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.
The company has a dividend yield of 0.97% with the ex dividend date set at 31-3-2023 (DMY).
Other points of data to note are a P/E ratio of 24.09, revenue per share of 43.84 and a 6.3% return on assets.
